Walleye Capital’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$732K Buy
30,753
+919
+3% +$17.6K ﹤0.01% 2391
2026
Q1
$526K Buy
29,834
+22,933
+332% +$461K ﹤0.01% 2627
2025
Q4
$136K Sell
6,901
-56,809
-89% -$1.02M ﹤0.01% 3735
2025
Q3
$1.11M Sell
63,710
-170,596
-73% -$2.53M ﹤0.01% 2003
2025
Q2
$3.28M Buy
234,306
+33,698
+17% +$543K 0.01% 1144
2025
Q1
$3.74M Buy
+200,608
New +$2.99M 0.02% 976
2024
Q4
Sell
-178,110
Closed -$2.11M 4782
2024
Q3
$2.11M Buy
178,110
+104,565
+142% +$989K ﹤0.01% 1901
2024
Q2
$575K Buy
+73,545
New +$480K ﹤0.01% 3395
2023
Q4
Sell
-17,170
Closed -$119K 4890
2023
Q3
$119K Buy
+17,170
New +$104K ﹤0.01% 3856
2023
Q1
Sell
-10,838
Closed -$127K 3890
2022
Q4
$127K Buy
+10,838
New +$132K ﹤0.01% 2274

Other funds holding ALHC

Walleye Capital's ALHC Position: Q2 2026 in Review

Walleye Capital increased its Alignment Healthcare (ALHC) stake by 3.1% in Q2 2026, buying an estimated $17.6K and bringing the position to 30,753 shares worth $732K. The position accounts for ﹤0.01% of the portfolio, ranked #2391.

Walleye Capital first reported a position in ALHC in Q4 2022 and has held it in 10 quarters since. The position peaked at $3.74M in Q1 2025. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Walleye Capital held 30,753 shares of Alignment Healthcare worth $732K as of Q2 2026.
  • Walleye Capital bought 919 Alignment Healthcare shares in Q2 2026, an estimated $17.6K.
  • Alignment Healthcare made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #2391 holding.
  • Walleye Capital first reported a position in Alignment Healthcare in Q4 2022 and has held it in 10 quarters since.
  • Walleye Capital's Alignment Healthcare position peaked at $3.74M in Q1 2025.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.